🇺🇸 FDA
Patent

US 9981968

Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders

granted A61PA61P35/00

Quick answer

US patent 9981968 (Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders) held by Northwestern University expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P35/00